Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
Mucopolysaccharidosis type I (MPSI) is a lysosomal storage disease caused by insufficient iduronidase (IDUA) activity. Here, the authors use an ex vivo genome editing approach to overexpress IDUA in human hematopoietic stem and progenitor cells and show it can phenotypically correct MSPI in mouse mo...
Saved in:
Main Authors: | Natalia Gomez-Ospina, Samantha G. Scharenberg, Nathalie Mostrel, Rasmus O. Bak, Sruthi Mantri, Rolen M. Quadros, Channabasavaiah B. Gurumurthy, Ciaran Lee, Gang Bao, Carlos J. Suarez, Shaukat Khan, Kazuki Sawamoto, Shunji Tomatsu, Nitin Raj, Laura D. Attardi, Laure Aurelian, Matthew H. Porteus |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/8f066f14a98c44ea90d2d9109e701772 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activity of daily living in mucopolysaccharidosis IVA patients: Evaluation of therapeutic efficacy
by: Hui Chen, et al.
Published: (2021) -
Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I
by: Ngoc Thi Bich Can, et al.
Published: (2021) -
Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
by: Samantha G. Scharenberg, et al.
Published: (2020) -
Author Correction: Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
by: Samantha G. Scharenberg, et al.
Published: (2020) -
Gene correction for SCID-X1 in long-term hematopoietic stem cells
by: Mara Pavel-Dinu, et al.
Published: (2019)